Carnegie Mellon University

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bayer, Twist Collaboration Gives German

Amylyx Hopes Sunnybrook Might Discover New Methods For Fighting ALS Although it is in the midst of a protracted effort to obtain US Food and Drug Administration approval for its investigational mitoch

Amgen, Inc. acknowledged during its business review on 8 February that drug pricing and competitive pressures are growing hurdles for the biopharmaceutical industry through the end of this decade. As

There are a lot of notable financial disclosures in BioNTech AG 's US Securities and Exchange Commission (SEC) filing indicating that the company may raise up to $100m in a future initial public offe